Skip to content

Colorectal Cancer Screening in Xinxiang City

Colorectal Cancer Screening in Xinxiang City

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06785714
Enrollment
25000
Registered
2025-01-21
Start date
2024-09-01
Completion date
2025-01-15
Last updated
2025-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

The primary objective of this study is to evaluate the sensitivity of the fecal protein dual-index test reagent for the detection of colorectal cancer (CRC).

Detailed description

The project uses fecal hemoglobin and transferrin dual-index combined with reagents that can be self-tested at home (referred to as fecal protein dual-index detection reagents), combined with colorectal cancer risk factor questionnaires, to carry out colorectal cancer screening in people of specific ages in the city, aiming to achieve early screening, early diagnosis and early treatment, and evaluate the effect of fecal protein dual-index detection reagents in early screening of colorectal cancer, so as to provide a scientific basis for optimizing the national screening program.

Interventions

None listed

Sponsors

Xinxiang Municipal Health Commission
CollaboratorUNKNOWN
Xinxiang Center for Disease Control and Prevention
CollaboratorUNKNOWN
Xinxiang Central Hospital
CollaboratorOTHER
The Affiliated People's Hospital of Xinxiang Medical University
CollaboratorUNKNOWN
The Third Affiliated Hospital of Xinxiang Medical College
CollaboratorUNKNOWN
Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
The First Affiliated Hospital of Xinxiang Medical College
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

1. Subjects aged 45-74 years at time of consent 2. Have not had gastrointestinal resection

Exclusion criteria

1. Previous history of colorectal cancer 2. Patients who have been confirmed to have other malignant neoplastic diseases of the digestive system 3. Patients with severe heart, brain, lung disease or liver and kidney dysfunction or insufficiency 4. Those with severe mental disorders and language communication disorders 5. History of contraindications to colonoscopy 6. Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of colorectal cancer detection180 daysSensitivity of colorectal cancer detection
Specificity of advanced neoplasia detection180 daysSpecificity of advanced neoplasia detection

Secondary

MeasureTime frameDescription
Positive predictive value of colorectal cancer detection180 daysPositive predictive value of colorectal cancer detection
Negative predictive value of colorectal cancer detection180 daysNegative predictive value of colorectal cancer detection
Sensitivity and specificity of advanced adenoma detection180 daysSensitivity and specificity of advanced adenoma detection

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026